Davis Capital Management Has $725,000 Stock Position in Agilent Technologies, Inc. $A

Davis Capital Management raised its holdings in Agilent Technologies, Inc. (NYSE:A) by 2,365.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,325 shares of the medical research company’s stock after acquiring an additional 5,109 shares during the quarter. Davis Capital Management’s holdings in Agilent Technologies were worth $725,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of A. Massachusetts Financial Services Co. MA increased its stake in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares in the last quarter. AQR Capital Management LLC increased its stake in Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares during the period. SG Americas Securities LLC raised its holdings in shares of Agilent Technologies by 3,091.1% during the fourth quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock valued at $109,974,000 after purchasing an additional 782,888 shares during the period. Finally, Lazard Asset Management LLC boosted its position in shares of Agilent Technologies by 639.4% during the 2nd quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company’s stock worth $80,093,000 after purchasing an additional 586,931 shares in the last quarter.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $113.48 on Thursday. Agilent Technologies, Inc. has a 52 week low of $103.16 and a 52 week high of $160.27. The company’s 50 day moving average price is $117.67 and its two-hundred day moving average price is $133.53. The stock has a market cap of $32.07 billion, a P/E ratio of 24.92, a P/E/G ratio of 2.57 and a beta of 1.30. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st were given a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.52%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Barclays reduced their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Wells Fargo & Company decreased their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Finally, Morgan Stanley reduced their price target on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.